21st Century Oncology secures confirmation of plan of reorganization

By Caroline Salls

Pittsburgh, Jan. 11 – 21st Century Oncology Holdings, Inc.’s plan of reorganization was confirmed on Thursday by the U.S. Bankruptcy Court for the Southern District of New York.

As previously reported, 21st Century filed bankruptcy after reaching an agreement in principle with its senior lenders and bondholders on the terms of a comprehensive debt restructuring that is expected to reduce the company’s long-term net debt by more than $500 million.

Upon emergence, some of the company’s creditors will contribute $75 million of cash equity in the reorganized company. 21st Century said this cash will be used to pay off any borrowings under a debtor-in-possession facility in full, and any remaining cash will be used for general corporate purposes.

Under the Chapter 11 plan, the company’s MDL facility and first-lien credit agreements will be converted into two new term loan credit facilities.

Senior notes and some general unsecured claims will be converted into equity.

In addition, rights offerings will be available to all senior noteholders who are accredited investors for the rights to purchase their share of $200 million in new second-lien notes and new preferred equity interests with an initial liquidation value of $88.24 million.

New warrants will be provided to holders of existing equity interests, provided that all creditor classes as well as the equityholders vote to accept the proposed plan.

21st Century Oncology, a Fort Myers, Fla.-based provider of integrated cancer care services, filed for bankruptcy on May 25, 2017. The Chapter 11 case number is 17-22770.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.